Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using a special hip implant with vitamin E for active young patients

Official title: Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject

Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT05175300 · Data updated 2026-11-12

This study is testing if a special hip implant with vitamin E can help young and active people recover better and have longer-lasting results compared to a standard implant.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedMarch 24, 2023
Main results expectedMarch 2032
Study endsMarch 2032
Registry record updatedDecember 3, 2025
Trial IDNCT05175300 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 to 65 who require total hip arthroplasty and can provide informed consent.

Probably not a fit

Patients with a history of hip surgery, hip dysplasia, or other significant health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a highly cross-linked polyethylene acetabular component doped with vitamin E in total hip arthroplasty for young and active individuals. It is a single-centre, prospective, randomised, single-blind comparative study involving two groups: one receiving a ceramic-on-highly cross-linked polyethylene prosthesis and the other receiving a ceramic-on-ceramic prosthesis. The aim is to evaluate the performance and outcomes of these two types of implants in improving hip function and longevity.

Why it matters

Potential benefit: If successful, this approach could lead to improved outcomes and longer-lasting hip implants for young and active patients.

How similar studies have gone: Other studies have shown promise with ceramic and polyethylene combinations in hip arthroplasty, but the specific use of vitamin E in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 to 65 years,
* Who have signed their consent to participate in the study,
* For whom an indication for total hip arthroplasty has been given

Exclusion Criteria:

* History of hip surgery
* Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly)
* Hip dysplasia
* Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis
* Sequelae of neurological disease or stroke
* Pregnant or breastfeeding women
* Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol
* Patient likely not to return for follow-up visits
* Patient already included in another therapeutic study protocol
* Patient under court protection, guardianship or curatorship.

Where it's running

  • Hôpital Privé Jean Mermoz
    Lyon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.